최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기大韓韓醫學方劑學會誌 = Herbal formula science, v.26 no.3, 2018년, pp.237 - 250
조한별 (부산대학교 한의학전문대학원) , 김지영 (부산대학교 한의학전문대학원) , 김민성 (부산대학교 한의학전문대학원) , 안원근 (부산대학교 한의학전문대학원) , 이장천 (부산대학교 한의학전문대학원)
Objectives : This study is a pharmacological network approach, aimed to identify the potential active compounds contained in Curcumae Radix, and their associated targets, to predict the various bio-reactions involved, and finally to establish the cornerstone for the deep-depth study of the represent...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
서구화된 식생활을 비롯한 생활습관과 교통수단의 발달은 건강에 어떤 영향을 미치는가? | 서구화된 식생활을 비롯한 생활습관과 교통수단의 발달과 같은 현대인이 처한 환경적인 요인은 편리한 이면에 건강에 유해한 영향을 미치는 경우도 많다. 과도한 지방의 축적이 혈중 지질 대사의 이상을 초래하여 이상지질혈증(dyslipidemia), 특히 고지혈증(hyperlipidemia)을 유발한다1). 이는 대사증후군 구성요소의 하나이며, 혈중지질농도를 저하시키기 위해 약물 복용 환자의 수가 증가함에 따라 건강보험공단의 재정악화의 주된 원인이 되고 있다. | |
천연물을 원료로 하는 한약의 특징은 무엇인가? | 스타틴제는 효과적으로 혈중 지질 농도를 낮추는 반면 다양한 부작용 및 내성의 문제를 동반 하는데 대표적인 부작용으로는 근육병증 및 횡문근 융해와 같은 이상 반응이 보고되었고3,4), 가족성 고지혈증과 같은 유전변이에 의한 이상지질혈증에는 효과가 미미한 것으로 보고되었다5). 천연물을 원료로 하는 한약은 대부분 독성이 없거나 약하며, 서양의학의 화학 합성 약품의 독성에 비해 비교적 약하여 장기적으로 복용환자에게는 더욱 효율적이다. | |
스타틴제의 특징은 무엇인가? | 현재까지 스타틴 계열의 약물이 혈중 지질강하제로 가장 광범위하게 사용되어 왔다. 스타틴제는 효과적으로 혈중 지질 농도를 낮추는 반면 다양한 부작용 및 내성의 문제를 동반 하는데 대표적인 부작용으로는 근육병증 및 횡문근 융해와 같은 이상 반응이 보고되었고3,4), 가족성 고지혈증과 같은 유전변이에 의한 이상지질혈증에는 효과가 미미한 것으로 보고되었다5). 천연물을 원료로 하는 한약은 대부분 독성이 없거나 약하며, 서양의학의 화학 합성 약품의 독성에 비해 비교적 약하여 장기적으로 복용환자에게는 더욱 효율적이다. |
Navar-Boggan AM, Peterson ED, D'Agostino RB, Neely B, Sniderman AD, Pencina MJ. Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease. Circulation. 2015;131:451-8.
Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014;43: 69-77.
Kiortsis DN, Filippatos TD, Mikhailidis DP, Elisaf MS, Liberopoulos EN. Statin-associated adverse effects beyond muscle and liver toxicity. Atherosclerosis.2007;195(1):7-16.
Silva MA, Swanson AC, Gandhi PJ, Tataroni GR. Statin-related adverse events: a metaanalysis. Clin Ther. 2006;28:26-35.
Hartgers ML, Ray KK, Hovingh GK. New Approaches in Detection and Treatment of Familial Hypercholesterolemia. Curr Cardiol Rep. 2015;17:109.
Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci U S A. 2000;97:1433-37.
Ong ES, binte Apandi SN. Determination of berberine and strychnine in medicinal plants and herbal preparations by pressurized liquid extraction with capillary zone electrophoresis. Electrophoresis. 2001;22:2723-29
Van Der Graaf PH, Gabrielsson J. Pharmacokineticpharmacodynamic reasoning in drug discovery and early development. Future Med Chem. 2009;1:1371-74.
Herbology Textbook Committee for Nationwide School of Korean Medicine Complilation. Herbology 2nd. Seoul: Yeongrimsa. 2017:452-3.
Han JM, Lee JS, Kim HG, Seol IC. Im HJ, Cho JH, et al. Synergistic effects of Artemisia iwayomogi and Curcuma longa radix on highfat diet-induced hyperlipidemia in a mouse model. J Ethnopharmacol. 2015;173:217-24.
Lu B, Xu L, Yu L, Zhang L. Extract of radix curcumae prevents gastric cancer in rats. Digestion. 2008;77:87-91.
Dong JY, Ma XY, Cai XQ, Yan PC, Yue L, Lin C, et al. Sesquiterpenoids from Curcuma wenyujin with anti-influenza viral activities. Phytochemistry. 2013;85:122-8.
Huang X, Ly B, Zhang S, Dai Q, Chen BB, Meng LN. Effects of radix curcumae-derived diterpenoid C on Helicobacter pylori-induced inflammation and nuclear factor kappa B signal pathways. World J Gastroenterol. 2013;19: 5085-93.
Lim CB, Ky N, Ng HM, Hamza MS, Zhao Y. Curcuma wenyujin extract induces apoptosis and inhibits proliferation of human cervical cancer cells in vitro and in vivo. Integr Cancer Ther. 2010;9:36-49.
Oh H, Park H, Ju MS, Jung S, Oh MS. Comparative study of anti-oxidant and anti-inflammatory activities between Curcumae longae Radix and Curcumae longae Rhizoma. Korean Journal of Herbology. 2010;25:83-91.
Nelson KM, Jahlin JL, Bisson J, Grahm J, Pauli GF, Walters MA. The Essential Medicinal Chemistry of Curcumin. J Med Chem. 2017; 60(5):1620-37.
Heger M. Drug Screening : Don’t discount all curcumin trial data. Nature. 2017;543:47.
Ding L, Li J, Song B, Xiao X, Zhang B, Qi M, et al. Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway. Toxicol Appl Pharmacol. 2016;304:99-109.
Jang EM, Choi MS, Jung UJ, Kim MJ, Kim HJ, Jeon SM, et al. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. Metabolism. 2008;57: 1576-83.
Adiwidjaja J, McLachlan AJ, Boddy AV. Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions. Expert Opin Drug Metab Toxicol. 2017;13:953-72.
Fazal Y, Fatima SN, Shahid SM, Mahboob T. Effects of curcumin on angiotensin-converting enzyme gene expression, oxidative stress and anti-oxidant status in thioacetamide-induced hepatotoxicity. J Renin Angiotensin Aldosterone Syst. 2015;16:1046-51.
Srivastava RM, Singh S, Dubey SK, Misra K, Khar A. Immunomodulatory and therapeutic activity of curcumin. Int Immunopharmacol. 2011;11:331-41.
Weber WM, Hunsaker LA, Abcouwer SF, Deck LM, Vander Jagt DL. Anti-oxidant activities of curcumin and related enones. Bioorg Med Chem. 2005;13:3811-20.
Suh SY, An WG. Systems Pharmacological Approach of Pulsatillae Radix on Treating Crohn's Disease. Evid Based Complement Alternat Med. 2017:4198035.
Yu H, Chen J, Xu X, Li Y, Zhao H, Fang Y, et al. A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data. PLoS One. 2012;7:e37608.
Shen M, Tian S, Li Y, Li Q, Xu X, Wang J, Hou T. Drug-likeness analysis of traditional Chinese medicines: 1. Property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines. J Cheminform. 2012;4:31.
Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y, et al. A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 2012; 13(6): 6964-82.
Hubatsch I, Ragnarsson EG, Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc. 2007;2:2111-19.
Wu CH, Apweiler R, Bairoch A, Natale DA, Barker WC, Boeckmann B, et al. The Universal Protein Resource (UniProt): an expanding universe of protein information. Nucleic Acids Res.2006;34:D187-91.
Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27:431-2.
Liu F, Bai X, Yang FQ, Zhang XJ, Hu Y, Li P, Wan JB. Discriminating from species of Curcumae Radix (Yujin) by a UHPLC/QTOFMS- based metabolomics approach. Chin Med. 2016;11:21.
Goldwasser J, Cohen PY, Yang E, Balaguer P, Yarmush ML, Nahmias Y. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha. PLoS One. 2010;5:e12399.
Mulvihill EE, Alister EM, Sutherland BG, Telford DE, Sawyez CG, Edwards JY, et al. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes. 2009;58:2198-210.
Hussein O, Grosovski M, Lasri E, Svalb S, Ravid U, Assy N. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J Gastroenterol. 2007;13:361-8.
Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin. Invest. 2005;115: 1343-51.
Heinemann T, Kullak-Ublick GA, Pietruck B, von Bergmann K. Mechanisms of action of plant sterols on inhibition of cholesterol absorption. Comparison of sitosterol and sitostanol. Eur J Clin Pharmacol. 1991;40: S59-63.
Crooke RM, Graham MJ, Lemonidis KM, Whipple CP, Koo S, Perera RJ. An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis. J Lipid Res. 2005;46:872-84.
Soh J, Iqbal J, Queiroz J, Fernandez-Hernando C, Hussain MM. MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat Med. 2013;19:892-900.
Rai S, Bhatnagar S. Hyperlipidemia, Disease Associations, and Top 10 Potential Drug Target: A Network View. OMICS. 2016;20:152-68.
Chaudhary LR, Hruska KA. Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. J Cell Biochem. 2003; 89:1-5.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.